Case Review Form

      * Denotes required field.


      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address




      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

FDA says Yaz, Yasmin other contraceptives pose blood clot risk

Filed April 12th, 2012 Laurie

The Food and Drug Administration believes women taking drosperinone-based contraceptives like Yaz, Yasmin, Beyaz, and Safyral face a greater risk of blood clots than those taking another form of birth control.

The agency has been conducting a review of these relatively newer forms of pill-form contraception due to numerous reports of women suffering fatal blood clots soon after taking these drugs. The FDA will include the findings of its own recently-completed review of these drugs in safety information packaged with them.

Furthermore, regulators are advising women to discuss this specific risk and their likelihood of developing severe blood clots with their prescribing physicians. Additionally, doctors are being advised to identify patients who may already be facing a higher risk of blood clots before they prescribe them a contraceptive containing drosperinone.

In its study, the FDA stops short in identifying women who face this risk over others, nor does the study indicate how much greater of a risk of blood clots women face from the drugs over another form of contraception.

In studies obviously discounted or not used by the agency, contraceptives like Yaz and Yasmin have been associated with a much greater risk of blood clots than other, more standard forms of birth control. The FDA has even chastised the makers of Yaz, Bayer, for an ad campaign that downplayed any health risks associated with the drugs.

A European study recently conducted identifies more than 200 deaths that could be attributed to blood clot side effects caused by Yasmin.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!